An innovative gene-editing strategy could establish a new way for the body to manufacture therapeutic proteins—including ...
Gene‑edited HPSCs programmed to make therapeutic antibodies and proteins show long‑lasting, boostable immunity in mouse models.
Placebo effects, in which patients experience relief without therapeutic treatment, increasingly have been considered as ...